It was found that low proportion of baseline TLR3 expressing CD14+ monocytes was a single predictor of cEVR in chronic hepatitis C patients with antiviral treatment [odds ratio (OR)  = 2.11, 95% confidence intervals (CI) (1.15–3.88), P = 0.023]. This evidence concerns the gene CD14 and chronic hepatitis C virus infection.